BTIG raised the firm’s price target on HashiCorp to $27 from $25 and keeps a Buy rating on the shares. The company delivered better than expected Q4 results, with operating income seen as “substantially better” than the Street estimates, the analyst tells investors in a research note. Bears will likely point towards a lower-than-expected FY25 operating income guide as reason to remain cautious on the name, though sentiment on HashiCorp has been negative, and trends are now moving in the right direction, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HCP:
- HashiCorp Announces Fourth Quarter and Fiscal Year 2024 Financial Results
- HCP Upcoming Earnings Report: What to Expect?
- Moderna downgraded, Gap upgraded: Wall Street’s top analyst calls
- HashiCorp upgraded to Overweight from Equal Weight at Morgan Stanley
- HashiCorp to announce fourth quarter and fiscal year 2024 financial results Mar. 5, 2024